- Download 569
- File Size 397.34 KB
- File Count 1
- Create Date 10/08/2023
- Last Updated 10/08/2023
NANOPARTICLE BASED DRUG DELIVERY SYSTEMS FOR TARGETING TUMOR MICRO ENVIRONMENT
Krithika K, Nikita Bagade, Yeshaswini Radhakrishnan, Dr.Praveen Kumar Gupta
Department of Biotechnology,
R V College of engineering, Bangalore, India
Abstract
Nanoparticle-based drug delivery systems have emerged as promising tools in cancer therapy, offering enhanced precision and effectiveness in targeting tumor cells while minimizing damage to healthy tissues. This review provides a comprehensive exploration of the tumor microenvironment, emphasizing its critical role in cancer progression. It highlights the significance of targeted drug delivery in improving treatment outcomes and introduces nanoparticle-based delivery systems as innovative strategies to address these challenges.
The first section delves into various types of nanoparticles used for tumor targeting. Liposomes, known for their versatility and biocompatibility, are discussed alongside examples of liposome-based drug delivery systems tailored for tumor-specific applications. Polymeric nanoparticles, employing a range of polymers, offer unique advantages and applications in tumor targeting. Metallic nanoparticles, with distinctive properties, have shown promise in drug delivery systems designed to target tumors effectively.
The design considerations for tumor targeting form the core of the third section. Passive targeting exploits the Enhanced Permeability and Retention (EPR) effect, and strategies to enhance this approach using nanoparticles are explored. Active targeting methods, involving ligand-mediated and biomarker-specific approaches, are detailed. Additionally, combination strategies and stimulus-responsive drug release systems are examined for their potential synergistic effects in improving tumor targeting.
The challenges and opportunities associated with nanoparticle-based drug delivery systems are outlined in the fourth section. Overcoming physiological barriers, optimizing drug release kinetics, and ensuring safety and biocompatibility are key concerns addressed in this section. Strategies to bypass systemic clearance and immune responses, achieve controlled drug release, and enhance biocompatibility are discussed in depth.
The review also delves into clinical applications and future directions, highlighting examples of successful nanoparticle-based drug delivery systems in preclinical and clinical studies. Challenges in translating research to clinical practice are acknowledged, paving the way for a discussion on emerging technologies and future perspectives. Advances in nanotechnology, coupled with potential areas for further research, underscore the exciting prospects for nanoparticle-based drug delivery systems in cancer treatment.
In conclusion, this review synthesizes the intricate landscape of nanoparticle-based drug delivery systems for tumor targeting. It emphasizes the substantial progress made in this field, showcasing its potential to revolutionize cancer therapy. As the research landscape continues to evolve, nanoparticle-based drug delivery systems hold the promise of reshaping the future of cancer treatment through their precise and efficacious targeting capabilities.
